Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 8,580 shares at $40.00 ($343K) on 2017-03-24, disclosed to the SEC on 2017-04-27.
Open-market sale of $343k HAE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |